Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly Stock The Motley Fool 2d
Collectors Marc Andreessen and Ken Griffin Among Biggest Donors to Midterm Elections ARTnews Magazine 8d
Billionaire Ken Griffin Is Shifting His AI Bets. Here's What He's Buying and Selling. The Motley Fool 11:38 Fri, 28 Aug
“Transformational”: What we know about Ken Griffin’s rumored $700M+ purchase of Mana Wynwood The Real Deal 19:54 Thu, 27 Aug
What data says about Tukaram Mundhe’s 100-day stint as FDA Commissioner The Hindu 4h FDA India Article paywall
Watson-Marlow to showcase fluid management solutions at European events European Pharmaceutical Manufacturer 16h
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore The Hindu Business Line 1d Novartis Pfizer India
AstraZeneca's breast cancer drug granted accelerated approval in the US ShareCast 1d AstraZeneca FDA FTSE 100 Article paywall
Lilly to acquire Merida Biosciences in deal worth up to $2.875bn PMLiVE 6d Central America Pharma Latin America All sources
Eli Lilly has been on an acquisition spree. How much could its latest deals boost the stock? The Motley Fool 10h Mounjaro Novo Nordisk Pharma All sources
Eli Lilly is acquiring merdia biosciences for up to $2.88 Billion. Here's what that means for investors. The Motley Fool 7d Central America Pharma Biotechnology
Veteran JP Morgan manager announces retirement Portfolio Adviser 6d Altruist Vanguard World Banking All sources
AUM giants lose to smaller equity funds: The surprising gap in 1-year returns investors need to know about Mint 2d AUM All sources
Norway Sovereign Fund plans to boost JGB Holdings Qazinform 2d Norwegian Politics Norway Bonds All sources
M&G Group records £2.2bn in asset management inflows in the first half of 2026 Portfolio Adviser 5d FTSE 100 M&G All sources
